This study found that the proportion of CD4+Tn cells was decreased in patients with breast cancer, while the absolute number and proportion of CD4+CD57+T and CD4+ PD-1+T cells were significantly increased compared with those in patients with benign tumors. The gene discussed is CD4; the disease is breast carcinoma.